NT-proBNP

Pulmovant Advances Mosliciguat Into Phase 3 After Positive PHocus Data

WALTHAM, Massachusetts — September 8, 2026 Pulmovant announced positive topline results from the Phase 2 PHocus study of mosliciguat...

By cGxPwire Editor
September 9, 2026

MedTech

Pulnovo Medical Reports PADN Trial Results in NEJM

Shanghai, China, September 3, 2026 Pulnovo Medical announced clinical results from the PADN-HF-PH randomized controlled trial, evaluating pulmonary artery...

By cGxPwire Editor
September 4, 2026

MedTech

Curium Acquires Abscint to Expand Oncology PET Pipeline

Boston, Mass. & Liège, Belgium, August 10, 2026 Curium announced the completion of its acquisition of Abscint SA, a...

By cGxPwire Editor
August 11, 2026

Pharma

Tenax Therapeutics Reports Phase 3 LEVEL Results for TNX-103

Chapel Hill, N.C., August 10, 2026 Tenax Therapeutics, Inc. announced topline results from the Phase 3 LEVEL clinical trial...

By cGxPwire Editor
August 11, 2026

We work Hard to get you posted with latest updates

Unwrap our new Directory

Pulmovant Advances Mosliciguat Into Phase 3 After Positive PHocus Data

Pulnovo Medical Reports PADN Trial Results in NEJM

Curium Acquires Abscint to Expand Oncology PET Pipeline

Tenax Therapeutics Reports Phase 3 LEVEL Results for TNX-103